Glycogen storage disease type III in Inuit children

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 3, 2005, Pages 355-358

  Zimakas, Paul James A ^a   Rodd, Celia J ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME DEGRADATION; ESKIMO; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 3; HIGH RISK POPULATION; HUMAN; HYPOGLYCEMIA; INFANT; LIVER CIRRHOSIS; MALE; MUSCLE WEAKNESS; PATIENT CARE; POPULATION RESEARCH;

EID: 13444287964     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1031589     Document Type: Article

References (14)

1. Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT. Glycogen Storage Disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 1992;116:896-900.
2. Wolfsdorf JI, Holm IA, Weinstein DA. Glycogen storage diseases: phenotypic, genetic, and biochemical characteristics, and therapy. Endocrinol Metab Clin North Am 1999; 28(4):801-23.
3. Coleman RA, Winter HS, Wolf B, Chen YT. Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features. J Inherit Metab Dis 1992;15: 869-81.
4. Haagsma EB, Smit GP, Niezen-Koning KE, Gouw AS, Meennan L, Slooff MJ. Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology 1997;25(3):537-40.
5. Siciliano M, De Candia E, Ballarin S, Vecchio FM, Servidei S, Annese R, et al. Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. J Clin Gastroenterol 2000;31(1):80-2.
6. Matern D, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999;158(Suppl 2):S43-8.
7. Statistics Canada. 2001 Aboriginal population profile. Ottawa: Census Division, Statistics Canada; 2001.
8. Parvari R, Moses S, Shen J, Hershkovitz E, Lerner A, Chen YT. A single-base deletion in the 3′-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type III in a population of North African Jewish patients. Eur J Hum Genet 1997;5(5):266-70.
9. Bonatto SL, Salzano FM. A single and early migration for the peopling of the Americas supported by mitochondrial DNA sequence data. Proc Natl Acad Sci U S A 1997;94(5):1866-71.
10. Shen JJ, Chen YT. Molecular characterization of glycogen storage disease type III. Curr Mol Med 2002;2(2):167-75.
11. Scriver CR, Beaudet AL, Sly WS, Valle DL, editors. The metabolic and molecular basis of inherited disease. 7th ed. Vol 1. New York: McGrawHill; 2001. p. 949-50.
12. Moses SW, Wanderman KL, Myroz A, Frydman M. Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 1989;148(8):764-6.
13. Lee PJ, Deanfield JE, Burch M, Baig K, McKenna WJ, Leonard JV. Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Am J Cardiol 1997;79(6):834-8.
14. Yang BZ, Stewart C, Ding JH, Chen YT. Type III glycogen storage disease: an adult case with mild disease but complete absence of debrancher protein. Neurmuscul Disord 1991;1(3):173-6.